Active Clinical Research: Pancreatic Cancer
Comprehensive Cancer Centers is running the following clinical research studies for pancreatic cancer.
A Phase 3 Multicenter, Open-label, Randomized, 2 Arm Study of Adjuvant Daraxonrasib versus Standard of Care Observation Following Completion of Neoadjuvant and/or Adjuvant Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma (PDAC).
Study#: i3378
Contact Us: For information about this clinical study, Email Us.
A Phase 3 Randomized, Open-Label Study of Atebimetinib in Combination with the Modified Gemcitabine and nab-Paclitaxel Regimen Versus the Standard Gemcitabine and nab-Paclitaxel Regimen for the Treatment of Patients with Metastatic Pancreatic Ductal Adenocarcinoma Cancer (MAPKeeper 301).
Study#: i3380
Contact Us: For information about this clinical study, Email Us.